Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
Your fast track to the ultramodern lab
Your fast track to the ultramodern lab
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
Your fast track to the ultramodern lab
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
Your fast track to the ultramodern lab
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
How can an ultramodern laboratory, 100% specialized in uropathology, benefit you and your patients?
Welcome to our booth at Urologidagarna in Malmö, October 5–7. Let’s talk about how you can get visual and intuitive pathology reports within 5 days with high and consistent quality, created by world-leading AI in collaboration with experienced uropathologists.
Your patient, our priority
Urologidagarna i Malmö, booth #43
Malmö Live
October 5–7, 2022
Malmö Live
October 5–7, 2022
Learn more about Inify Laboratories
Watch the video presentation
One out of seven will be diagnosed with prostate cancer
Handling of prostate biopsies makes up an increasing amount of workload for today’s pathology labs. Here, powerful decision support tools – such as Inify Prostate – have the potential to save valuable time for the pathologist, while ensuring a more objective, consistent and accurate evaluation of the biopsies.
PANEL TALK
Successful first months of laboratory operation: Panel talk Q3 report 2023
Inify’s Q3 report is published and highlights continuous diagnostic operation and very positive feedback from customers. Inify’s CEO Fredrik Palm and Chief Medical Officer Claes Lindh talks about what this means for patients in practice in this panel talk together with Ole Eikeland.
PANEL TALK
Over 1,000 patients diagnosed: Panel talk Q2 report 2024
Inify reports sales of SEK 3.6 million in the quarter – up 62% compared to Q1. By the end of June, the laboratory had been open for over a year and had diagnosed more than 1,000 patients. More details about the laboratory operations and its success factors are discussed in a panel talk led by Ole Eikeland with Inify's CEO Fredrik Palm and Laboratory Director Emelie Edvigsson.
-
Investor News
Panel talk about Inify’s second quarter 2024
2024-09-09
News
Finansavisen highlights Inify Laboratories
2023-07-03